|
Faculty
Ph.D., Medical College of Ohio, 1999. Mucosal Immunity Research Group The identification of novel therapeutic/prophylactic vaccine strategies and combinatorial antimicrobial therapies are of continued interest in the field of public health. Despite a better understanding of systemic immune mechanisms, there are still challenges facing the vaccine field particularly in the area of mucosal defenses. Mucosal surfaces form the major interface between the host and the environment, and constitute the first line of defense against pathogens. The mammalian mucosal immune system has evolved into an intricate network of tissues, lymphoid and mucus membrane-associated cells and effector mechanisms for host protection. The mucosal surface area in humans is estimated to be 300-400 square meters and represents a significant portal of entry for pathogens. Thus, there is an important need to understand the basic mechanisms of immune defenses at these specialized sites. Our research program has focused on understanding host-microbe interactions and identifying approaches to induce optimal mucosal protection and immunity. The current research efforts in the laboratory include: 1. Intranasal based vaccine approach against genital Chlamydia
trachomatis infection. 2. Respiratory defenses against pulmonary tularemia. Recent Publications Cong, Y., Jupelli, M., Guentzel, M. N., Zhong, G., Murthy, A.K., Arulanandam, B.P. Intranasal immunization with chlamydial protease-like activity factor and CpG deoxynucleotides enhances protective immunity against genital Chlamydia muridarum infection. Vaccine. 25:3773-3780. 2007. Murthy, A. K., Chambers, J.P., Meier, P.A. Zhong, G., Arulanandam, B.P. Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology and is highly dependent upon endogenous IFN-g production. Infect. Immuno. 75:666-676. 2007. Rodriguez, A.R., Arulanandam, B.P., Hodara, V.L, McClure, H.M., Cobb, E.K., Salas, M.T., White, R. Murthy, K.K. Influence of IL-15 on CD8+ natural killer cells in human immunodeficienct virus type 1 infected chimpanzees. J. Gen. Virol. 88:641-651, 2007. Murphey, C., Murthy, A.K., Meier P.A., Guentzel, M.N., Zhong, G, Arulanandam, B.P. The protective efficacy of chlamydial protease-like activity factor vaccination is dependent upon CD4+ T cells. Cell. Immuno. 242:110-117. 2007. Murthy, A. K., Cong, Y., Forsthuber, T.G., Zhong, G., Guentzel, M.N., Arulanandam, B.P. Chlamydial protease-like activity factor induces protective immunity against genital chlamydial infection in transgenic mice that express the human HLA-DR4 allele. Infect. Immuno. 74:6722-6729, 2006. Chen, C., Chen, D., Sharma, J., Cheng, W., Zhong, Y., Liu, K., Shain, R., Arulanandam, B., Zhong, G. The hypothetical protein CT813 is localized in the C. trachomatis inclusion membrane and immunogenic in women urogenitally infected with C. trachomatis. Infect. Immuno. 74:4286-4840., 2006. Daum, L.T., Canas, L.C., Klimov, A.I., Shaw, M.W., Shreshta, S.K., Myint, K.S., Reese, F., Niemeyer, D., Arulanandam, B.P., Chambers, J.P. Molecular analysis of isolates from influenza B outbreaks in the US and Nepal, 2005. Archives of Virology. 151:1863-1874. 2006. Pammitt, M., Klose, Raulie, E.K., Lauriano, C.M., Arulanandam, B.P. Intranasal vaccination with a defined attenuated Francisella novicida strain induces IFN-g-dependent antibody-mediated protection tularemia. Infect. Immuno. 74: 2063-2071. 2006. Murthy, A.K., Dubose, C.N., Banas, J.A., Coalson, J.J. Arulanandam, B.P. The contribution of polymeric immunoglobulin receptor in the regulation of intestinal inflammation upon Dextran Sulfate Sodium induced colitis. J. Gastroentero. Hepatalo. 21:1372-1380. 2006. Dong, F., Zhong, Y., Arulanandam, B., Zhong, G. Production of proteolytically active CPAF by 5 different chlamydia species. Infect. Immuno. 73:1868-1872. 2005. Current Laboratory Members Jieh-Juen Yu, Ph.D., Research Assistant Professor;
jiehjuen.yu@utsa.edu Past Laboratory Members Erin Raulie, M.S.
|